90 participants
Study to Evaluate Safety, Dose Response and Immunogenicity of the Measles Vaccine MVA mBN85B in Healthy Children Aged 6 Months to 6 Years
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2012-07-27
- Start Date:
- 2009-06-30
- Completion:
- 2010-07-31
Conditions
- Measles
Interventions
- BIOLOGICAL
No Results Yet